{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:54:59Z","timestamp":1767963299982,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:00:00Z","timestamp":1340928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12012-012-9177-8","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T17:07:54Z","timestamp":1340903274000},"page":"326-340","source":"Crossref","is-referenced-by-count":44,"title":["Differentiation-Dependent Doxorubicin Toxicity on H9c2 Cardiomyoblasts"],"prefix":"10.1007","volume":"12","author":[{"given":"Ana F.","family":"Branco","sequence":"first","affiliation":[]},{"given":"Susana F.","family":"Sampaio","sequence":"additional","affiliation":[]},{"given":"Ana C.","family":"Moreira","sequence":"additional","affiliation":[]},{"given":"Jon","family":"Holy","sequence":"additional","affiliation":[]},{"given":"Kendall B.","family":"Wallace","sequence":"additional","affiliation":[]},{"given":"Ines","family":"Baldeiras","sequence":"additional","affiliation":[]},{"given":"Paulo J.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Vilma A.","family":"Sard\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,6,29]]},"reference":[{"key":"9177_CR1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11912-010-0129-9","volume":"12","author":"JM Fulbright","year":"2010","unstructured":"Fulbright, J. M., Huh, W., Anderson, P., & Chandra, J. (2010). Can anthracycline therapy for pediatric malignancies be less cardiotoxic? Current Oncology Reports, 12, 411\u2013419.","journal-title":"Current Oncology Reports"},{"key":"9177_CR2","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1053\/j.seminoncol.2006.04.019","volume":"33","author":"SE Lipshultz","year":"2006","unstructured":"Lipshultz, S. E. (2006). Exposure to anthracyclines during childhood causes cardiac injury. Seminars in Oncology, 33, S8\u201314.","journal-title":"Seminars in Oncology"},{"key":"9177_CR3","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archinternmed.2010.233","volume":"170","author":"HJ Pal van der","year":"2010","unstructured":"van der Pal, H. J., van Dalen, E. C., Hauptmann, M., Kok, W. E., Caron, H. N., van den Bos, C., et al. (2010). Cardiac function in 5-year survivors of childhood cancer: A long-term follow-up study. Archives of Internal Medicine, 170, 1247\u20131255.","journal-title":"Archives of Internal Medicine"},{"key":"9177_CR4","first-page":"75","volume":"9","author":"H Broder","year":"2008","unstructured":"Broder, H., Gottlieb, R. A., & Lepor, N. E. (2008). Chemotherapy and cardiotoxicity. Reviews in Cardiovascular Medicine, 9, 75\u201383.","journal-title":"Reviews in Cardiovascular Medicine"},{"key":"9177_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","volume":"32","author":"EA Lefrak","year":"1973","unstructured":"Lefrak, E. A., Pitha, J., Rosenheim, S., & Gottlieb, J. A. (1973). A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer, 32, 302\u2013314.","journal-title":"Cancer"},{"key":"9177_CR6","first-page":"49","volume":"18","author":"L Steinherz","year":"1991","unstructured":"Steinherz, L., & Steinherz, P. (1991). Delayed cardiac toxicity from anthracycline therapy. Pediatrician, 18, 49\u201352.","journal-title":"Pediatrician"},{"key":"9177_CR7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCULATIONAHA.109.902221","volume":"121","author":"C Huang","year":"2010","unstructured":"Huang, C., Zhang, X., Ramil, J. M., Rikka, S., Kim, L., Lee, Y., et al. (2010). Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice. Circulation, 121, 675\u2013683.","journal-title":"Circulation"},{"key":"9177_CR8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.109.895771","volume":"121","author":"A Angelis De","year":"2009","unstructured":"De Angelis, A., Piegari, E., Cappetta, D., Marino, L., Filippelli, A., Berrino, L., et al. (2009). Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation, 121, 276\u2013292.","journal-title":"Circulation"},{"key":"9177_CR9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.freeradbiomed.2008.09.006","volume":"45","author":"EA Konorev","year":"2008","unstructured":"Konorev, E. A., Vanamala, S., & Kalyanaraman, B. (2008). Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes. Free Radical Biology and Medicine, 45, 1723\u20131728.","journal-title":"Free Radical Biology and Medicine"},{"key":"9177_CR10","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/annonc\/mdn396","volume":"19","author":"HA Azim Jr","year":"2008","unstructured":"Azim, H. A., Jr, Peccatori, F. A., Scarfone, G., Acaia, B., Rossi, P., Cascio, R., et al. (2008). Anthracyclines for gestational breast cancer: Course and outcome of pregnancy. Annals of Oncology, 19, 1511\u20131512.","journal-title":"Annals of Oncology"},{"key":"9177_CR11","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1345\/aph.1H289","volume":"40","author":"MS Lam","year":"2006","unstructured":"Lam, M. S. (2006). Treatment of Burkitt\u2019s lymphoma during pregnancy. Annals of Pharmacotherapy, 40, 2048\u20132052.","journal-title":"Annals of Pharmacotherapy"},{"key":"9177_CR12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1592\/phco.25.3.438.61590","volume":"25","author":"JR Kerr","year":"2005","unstructured":"Kerr, J. R. (2005). Neonatal effects of breast cancer chemotherapy administered during pregnancy. Pharmacotherapy, 25, 438\u2013441.","journal-title":"Pharmacotherapy"},{"key":"9177_CR13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ygyno.2010.08.019","volume":"119","author":"K Calsteren Van","year":"2010","unstructured":"Van Calsteren, K., Verbesselt, R., Beijnen, J., Devlieger, R., De Catte, L., Chai, D. C., et al. (2010). Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecologic Oncology, 119, 594\u2013600.","journal-title":"Gynecologic Oncology"},{"key":"9177_CR14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-4827(76)90447-X","volume":"98","author":"BW Kimes","year":"1976","unstructured":"Kimes, B. W., & Brandt, B. L. (1976). Properties of a clonal muscle cell line from rat heart. Experimental Cell Research, 98, 367\u2013381.","journal-title":"Experimental Cell Research"},{"key":"9177_CR15","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/01.RES.69.6.1476","volume":"69","author":"J Hescheler","year":"1991","unstructured":"Hescheler, J., Meyer, R., Plant, S., Krautwurst, D., Rosenthal, W., & Schultz, G. (1991). Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circulation Research, 69, 1476\u20131486.","journal-title":"Circulation Research"},{"key":"9177_CR16","doi-asserted-by":"crossref","first-page":"29063","DOI":"10.1074\/jbc.274.41.29063","volume":"274","author":"C Menard","year":"1999","unstructured":"Menard, C., Pupier, S., Mornet, D., Kitzmann, M., Nargeot, J., & Lory, P. (1999). Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. Journal of Biological Chemistry, 274, 29063\u201329070.","journal-title":"Journal of Biological Chemistry"},{"key":"9177_CR17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3858\/emm.2011.43.8.049","volume":"43","author":"HL Zhu","year":"2011","unstructured":"Zhu, H. L., Wei, X., Qu, S. L., Zhang, C., Zuo, X. X., Feng, Y. S., et al. (2011). Ischemic postconditioning protects cardiomyocytes against ischemia\/reperfusion injury by inducing MIP2. Experimental & Molecular Medicine, 43, 437\u2013445.","journal-title":"Experimental & Molecular Medicine"},{"key":"9177_CR18","doi-asserted-by":"crossref","first-page":"e16239","DOI":"10.1371\/journal.pone.0016239","volume":"6","author":"XY Yu","year":"2011","unstructured":"Yu, X. Y., Chen, H. M., Liang, J. L., Lin, Q. X., Tan, H. H., Fu, Y. H., et al. (2011). Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: Macrophage migration inhibitory factor. PLoS One, 6, e16239.","journal-title":"PLoS One"},{"key":"9177_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cvr\/cvp384","volume":"86","author":"N Gurusamy","year":"2009","unstructured":"Gurusamy, N., Lekli, I., Mukherjee, S., Ray, D., Ahsan, M. K., Gherghiceanu, M., et al. (2009). Cardioprotection by resveratrol: A novel mechanism via autophagy involving the mTORC2 pathway. Cardiovascular Research, 86, 103\u2013112.","journal-title":"Cardiovascular Research"},{"key":"9177_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12012-010-9062-2","volume":"10","author":"JP Silva","year":"2010","unstructured":"Silva, J. P., Sardao, V. A., Coutinho, O. P., & Oliveira, P. J. (2010). Nitrogen compounds prevent h9c2 myoblast oxidative stress-induced mitochondrial dysfunction and cell death. Cardiovascular Toxicology, 10, 51\u201365.","journal-title":"Cardiovascular Toxicology"},{"key":"9177_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2121-8-11","volume":"8","author":"VA Sardao","year":"2007","unstructured":"Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R., & Wallace, K. B. (2007). Vital imaging of H9c2 myoblasts exposed to tert-butylhydroperoxide\u2013characterization of morphological features of cell death. BMC Cell Biol, 8, 11.","journal-title":"BMC Cell Biol"},{"key":"9177_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11010-011-0973-4","volume":"358","author":"JA Sipkens","year":"2011","unstructured":"Sipkens, J. A., Krijnen, P. A., Hahn, N. E., Wassink, M., Meischl, C., Smith, D. E., et al. (2011). Homocysteine-induced cardiomyocyte apoptosis and plasma membrane flip-flop are independent of S-adenosylhomocysteine: A crucial role for nuclear p47(phox). Molecular and Cellular Biochemistry, 358, 229\u2013239.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"9177_CR23","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1128\/AAC.00039-07","volume":"51","author":"KC Lund","year":"2007","unstructured":"Lund, K. C., Peterson, L. L., & Wallace, K. B. (2007). Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs. Antimicrobial Agents and Chemotherapy, 51, 2531\u20132539.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"9177_CR24","doi-asserted-by":"crossref","first-page":"H820","DOI":"10.1152\/ajpheart.00366.2006","volume":"292","author":"M Comelli","year":"2007","unstructured":"Comelli, M., Metelli, G., & Mavelli, I. (2007). Downmodulation of mitochondrial F0F1 ATP synthase by diazoxide in cardiac myoblasts: A dual effect of the drug. American Journal of Physiology. Heart and Circulatory Physiology, 292, H820\u2013829.","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"9177_CR25","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1038\/cddis.2011.65","volume":"2","author":"J Huelsenbeck","year":"2011","unstructured":"Huelsenbeck, J., Henninger, C., Schad, A., Lackner, K. J., Kaina, B., & Fritz, G. (2011). Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity. Cell Death & Disease, 2, e190.","journal-title":"Cell Death & Disease"},{"key":"9177_CR26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.carpath.2011.02.001","volume":"21","author":"TJ L\u2019Ecuyer","year":"2011","unstructured":"L\u2019Ecuyer, T. J., Aggarwal, S., Zhang, J. P., & Van der Heide, R. S. (2011). Effect of hypothermia on doxorubicin-induced cardiac myoblast signaling and cell death. Cardiovascular Pathology, 21, 96\u2013104.","journal-title":"Cardiovascular Pathology"},{"key":"9177_CR27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10565-008-9070-1","volume":"25","author":"VA Sardao","year":"2009","unstructured":"Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R., & Wallace, K. B. (2009). Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets. Cell Biology and Toxicology, 25, 227\u2013243.","journal-title":"Cell Biology and Toxicology"},{"key":"9177_CR28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00280-009-0932-x","volume":"64","author":"VA Sardao","year":"2009","unstructured":"Sardao, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R., & Wallace, K. B. (2009). Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts. Cancer Chemotherapy and Pharmacology, 64, 811\u2013827.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"9177_CR29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12012-011-9112-4","volume":"11","author":"SL Pereira","year":"2011","unstructured":"Pereira, S. L., Ramalho-Santos, J., Branco, A. F., Sardao, V. A., Oliveira, P. J., & Carvalho, R. A. (2011). Metabolic remodeling during H9c2 myoblast differentiation: Relevance for in vitro toxicity studies. Cardiovascular Toxicology, 11, 180\u2013190.","journal-title":"Cardiovascular Toxicology"},{"key":"9177_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12012-011-9111-5","volume":"11","author":"AF Branco","year":"2011","unstructured":"Branco, A. F., Pereira, S. L., Moreira, A. C., Holy, J., Sardao, V. A., & Oliveira, P. J. (2011). Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line. Cardiovascular Toxicology, 11, 191\u2013203.","journal-title":"Cardiovascular Toxicology"},{"key":"9177_CR31","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1016\/j.bmc.2010.06.075","volume":"18","author":"J Holy","year":"2010","unstructured":"Holy, J., Kolomitsyna, O., Krasutsky, D., Oliveira, P. J., Perkins, E., & Krasutsky, P. A. (2010). Dimethylaminopyridine derivatives of lupane triterpenoids are potent disruptors of mitochondrial structure and function. Bioorganic & Medicinal Chemistry, 18, 6080\u20136088.","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"9177_CR32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248\u2013254.","journal-title":"Analytical Biochemistry"},{"key":"9177_CR33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0009-8981(03)00200-6","volume":"333","author":"A Pastore","year":"2003","unstructured":"Pastore, A., Federici, G., Bertini, E., & Piemonte, F. (2003). Analysis of glutathione: implication in redox and detoxification. Clinical Chimical Acta, 333, 19\u201339.","journal-title":"Clinical Chimical Acta"},{"key":"9177_CR34","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.bbagen.2011.09.008","volume":"1810","author":"T Umemoto","year":"2011","unstructured":"Umemoto, T., Furutani, Y., Murakami, M., Matsui, T., & Funaba, M. (2011). Endogenous Bmp4 in myoblasts is required for myotube formation in C2C12 cells. Biochimica et Biophysica Acta, 1810, 1127\u20131135.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9177_CR35","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/S0021-9258(17)35747-2","volume":"261","author":"JH Doroshow","year":"1986","unstructured":"Doroshow, J. H., & Davies, K. J. (1986). Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. Journal of Biological Chemistry, 261, 3068\u20133074.","journal-title":"Journal of Biological Chemistry"},{"key":"9177_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mito.2011.04.007","volume":"12","author":"C Chinopoulos","year":"2011","unstructured":"Chinopoulos, C., & Adam-Vizi, V. (2011). Modulation of the mitochondrial permeability transition by cyclophilin D: Moving closer to F(0)-F(1) ATP synthase? Mitochondrion, 12, 41\u201345.","journal-title":"Mitochondrion"},{"key":"9177_CR37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.devcel.2011.08.008","volume":"21","author":"JR Hom","year":"2011","unstructured":"Hom, J. R., Quintanilla, R. A., Hoffman, D. L., de Mesy Bentley, K. L., Molkentin, J. D., Sheu, S. S., et al. (2011). The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Developmental Cell, 21, 469\u2013478.","journal-title":"Developmental Cell"},{"key":"9177_CR38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2011.03.025","volume":"145","author":"ME Soriano","year":"2011","unstructured":"Soriano, M. E., & Scorrano, L. (2011). Traveling Bax and forth from mitochondria to control apoptosis. Cell, 145, 15\u201317.","journal-title":"Cell"},{"key":"9177_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1083\/jcb.201108059","volume":"195","author":"YB Chen","year":"2011","unstructured":"Chen, Y. B., Aon, M. A., Hsu, Y. T., Soane, L., Teng, X., McCaffery, J. M., et al. (2011). Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. Journal of Cell Biology, 195, 263\u2013276.","journal-title":"Journal of Cell Biology"},{"key":"9177_CR40","doi-asserted-by":"crossref","first-page":"e18005","DOI":"10.1371\/journal.pone.0018005","volume":"6","author":"JM Velez","year":"2011","unstructured":"Velez, J. M., Miriyala, S., Nithipongvanitch, R., Noel, T., Plabplueng, C. D., Oberley, T., et al. (2011). p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury. PLoS One, 6, e18005.","journal-title":"PLoS One"},{"key":"9177_CR41","doi-asserted-by":"crossref","first-page":"e22801","DOI":"10.1371\/journal.pone.0022801","volume":"6","author":"T Feridooni","year":"2011","unstructured":"Feridooni, T., Hotchkiss, A., Remley-Carr, S., Saga, Y., & Pasumarthi, K. B. (2011). Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes. PLoS One, 6, e22801.","journal-title":"PLoS One"},{"key":"9177_CR42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tox.2005.12.009","volume":"220","author":"PJ Oliveira","year":"2006","unstructured":"Oliveira, P. J., & Wallace, K. B. (2006). Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats\u2013relevance for mitochondrial dysfunction. Toxicology, 220, 160\u2013168.","journal-title":"Toxicology"},{"key":"9177_CR43","first-page":"771","volume":"61","author":"S Zhou","year":"2001","unstructured":"Zhou, S., Starkov, A., Froberg, M. K., Leino, R. L., & Wallace, K. B. (2001). Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Research, 61, 771\u2013777.","journal-title":"Cancer Research"},{"key":"9177_CR44","first-page":"506","volume":"71","author":"LE Davis","year":"1988","unstructured":"Davis, L. E., & Brown, C. E. (1988). Peripartum heart failure in a patient treated previously with doxorubicin. Obstetrics & Gynecology, 71, 506\u2013508.","journal-title":"Obstetrics & Gynecology"},{"key":"9177_CR45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00000441-199712000-00007","volume":"314","author":"A Katz","year":"1997","unstructured":"Katz, A., Goldenberg, I., Maoz, C., Thaler, M., Grossman, E., & Rosenthal, T. (1997). Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin. American Journal of the Medical Sciences, 314, 399\u2013400.","journal-title":"American Journal of the Medical Sciences"},{"key":"9177_CR46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2004.04.005","volume":"200","author":"PJ Oliveira","year":"2004","unstructured":"Oliveira, P. J., Bjork, J. A., Santos, M. S., Leino, R. L., Froberg, M. K., Moreno, A. J., et al. (2004). Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicology and Applied Pharmacology, 200, 159\u2013168.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"9177_CR47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1134\/S000629790602012X","volume":"71","author":"PJ Oliveira","year":"2006","unstructured":"Oliveira, P. J., Santos, M. S., & Wallace, K. B. (2006). Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respiration. Biochemistry (Moscow), 71, 194\u2013199.","journal-title":"Biochemistry (Moscow)"},{"key":"9177_CR48","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2174\/138161211796904812","volume":"17","author":"GC Pereira","year":"2011","unstructured":"Pereira, G. C., Silva, A. M., Diogo, C. V., Carvalho, F. S., Monteiro, P., & Oliveiraalo, P. J. (2011). Drug-induced cardiac mitochondrial toxicity and protection: From doxorubicin to carvedilol. Current Pharmaceutical Design, 17, 2113\u20132129.","journal-title":"Current Pharmaceutical Design"},{"key":"9177_CR49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12012-007-0026-0","volume":"7","author":"JM Berthiaume","year":"2007","unstructured":"Berthiaume, J. M., & Wallace, K. B. (2007). Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment. Cardiovascular Toxicology, 7, 178\u2013191.","journal-title":"Cardiovascular Toxicology"},{"key":"9177_CR50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0304-4165(86)90180-7","volume":"884","author":"G Schopf","year":"1986","unstructured":"Schopf, G., Rumpold, H., & Muller, M. M. (1986). Alterations of purine salvage pathways during differentiation of rat heart myoblasts towards myocytes. Biochimica et Biophysica Acta, 884, 319\u2013325.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9177_CR51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1096\/fasebj.8.6.8168693","volume":"8","author":"A Hammes","year":"1994","unstructured":"Hammes, A., Oberdorf, S., Strehler, E. E., Stauffer, T., Carafoli, E., Vetter, H., et al. (1994). Differentiation-specific isoform mRNA expression of the calmodulin-dependent plasma membrane Ca(2+)-ATPase. FASEB Journal, 8, 428\u2013435.","journal-title":"FASEB Journal"},{"key":"9177_CR52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.febslet.2007.01.050","volume":"581","author":"AL Hunter","year":"2007","unstructured":"Hunter, A. L., Zhang, J., Chen, S. C., Si, X., Wong, B., Ekhterae, D., et al. (2007). Apoptosis repressor with caspase recruitment domain (ARC) inhibits myogenic differentiation. FEBS Letter, 581, 879\u2013884.","journal-title":"FEBS Letter"},{"key":"9177_CR53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-009-0052-2","volume":"327","author":"E Bregant","year":"2009","unstructured":"Bregant, E., Renzone, G., Lonigro, R., Passon, N., Di Loreto, C., Pandolfi, M., et al. (2009). Down-regulation of SM22\/transgelin gene expression during H9c2 cells differentiation. Molecular and Cellular Biochemistry, 327, 145\u2013152.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"9177_CR54","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00735923","volume":"32","author":"C Muller","year":"1993","unstructured":"Muller, C., Chatelut, E., Gualano, V., De Forni, M., Huguet, F., Attal, M., et al. (1993). Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: Comparison of bolus administration and continuous infusion. Cancer Chemotherapy and Pharmacology, 32, 379\u2013384.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"9177_CR55","first-page":"3417","volume":"43","author":"RF Greene","year":"1983","unstructured":"Greene, R. F., Collins, J. M., Jenkins, J. F., Speyer, J. L., & Myers, C. E. (1983). Plasma pharmacokinetics of adriamycin and adriamycinol: Implications for the design of in vitro experiments and treatment protocols. Cancer Research, 43, 3417\u20133421.","journal-title":"Cancer Research"},{"key":"9177_CR56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15216540500079093","volume":"57","author":"SM Cutts","year":"2005","unstructured":"Cutts, S. M., Nudelman, A., Rephaeli, A., & Phillips, D. R. (2005). The power and potential of doxorubicin-DNA adducts. IUBMB Life, 57, 73\u201381.","journal-title":"IUBMB Life"},{"key":"9177_CR57","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2174\/138945011795529047","volume":"12","author":"O Sharaf el dein","year":"2011","unstructured":"Sharaf el dein, O., Mayola, E., Chopineau, J., & Brenner, C. (2011). The adenine nucleotide translocase 2, a mitochondrial target for anticancer biotherapy. Current Drug Targets, 12, 894\u2013901.","journal-title":"Current Drug Targets"},{"key":"9177_CR58","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00726-009-0415-8","volume":"38","author":"M Govoni","year":"2010","unstructured":"Govoni, M., Bonavita, F., Shantz, L. M., Guarnieri, C., & Giordano, E. (2010). Overexpression of ornithine decarboxylase increases myogenic potential of H9c2 rat myoblasts. Amino Acids, 38, 541\u2013547.","journal-title":"Amino Acids"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-012-9177-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-012-9177-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-012-9177-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T20:55:43Z","timestamp":1642625743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-012-9177-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,29]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9177"],"URL":"https:\/\/doi.org\/10.1007\/s12012-012-9177-8","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,29]]}}}